Vaxart Chairman Michael J. Finney to retire Sept 30, 2025; board reduced to 5 members

Vaxart, Inc.

Dr. Finney retires as Chairman and from Science & Technology Committee effective Sept 30, 2025.
Board size reduced from six to five directors upon Finney's departure.
Retirement is for personal reasons; no disagreement with Company operations or policies.
CEO Steven Lo thanked Finney for 16+ years of service; board to discuss leadership this month.

item 5.02item 7.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.